Back to Search Start Over

Supplementary Figures from Exploiting Allosteric Properties of RAF and MEK Inhibitors to Target Therapy-Resistant Tumors Driven by Oncogenic BRAF Signaling

Details

Database :
OpenAIRE
Accession number :
edsair.doi.dedup.....1e30c7b1b59cf5578370905338ebbd54